9 results match your criteria: "NYU Langone Hospital-Brooklyn Brooklyn[Affiliation]"
Rev Urol
January 2020
NYU Grossman School of Medicine, New York, NY; Director of Urological Oncology, NYU Langone Hospital-Brooklyn Brooklyn, NY.
Rev Urol
January 2019
Vice Chair of Urology, NYU School of Medicine New York, NY.
Ann Vasc Surg
January 2021
Department of Vascular Surgery, NYU Langone Hospital - Brooklyn Brooklyn, NY.
We discuss the rare case of a 72-year-old female with a history of a nonhealing lower extremity ulcer that was biopsied, revealing malignant transformation to basal cell carcinoma (BCC). Although BCC is the most common malignancy worldwide, malignant transformation of nonhealing wounds is more often associated with squamous cell carcinoma. Current literature estimates the rate of BCC arising from venous stasis ulcer to occur between 1.
View Article and Find Full Text PDFRev Urol
January 2018
Department of Pediatric Urology, NYU Langone Hospital-Brooklyn Brooklyn, NY.
Rev Urol
January 2018
Department of Urology, NYU Langone Hospital-Brooklyn Brooklyn, NY.
Rev Urol
January 2018
Department of Urology, NYU Langone Hospital-Brooklyn Brooklyn, NY.
Rev Urol
January 2018
Department of Urology, NYU Langone Hospital-Brooklyn Brooklyn, NY.
Rev Urol
January 2018
Department of Urology, NYU Langone Hospital-Brooklyn Brooklyn, NY.
It is critically important to the evolving goals of prostate biopsy to find clinically significant cancer with lethal potential and avoid detection of indolent disease. Better tests and markers are required for improved detection of clinically significant prostate cancer and avoidance of biopsies in men with indolent disease. Currently, there are myriad alternative prostate cancer risk-assessment tests available derived from serum and urine that are designed to improve the specificity for detection of "significant" prostate cancer.
View Article and Find Full Text PDF